BioChange focuses on developing minimally invasive treatments to address unmet needs in human and veterinary medicine. Their flagship product, VetFoam™, is an injectable biodegradable scaffold designed to stimulate tissue growth for treating urinary incontinence in female dogs. The foam remodels the urethral wall, offering long-term continence with minimal side effects. The company is committed to advancing this technology for broader applications in healthcare through strategic collaborations.